Gilteritinib as Post-Transplant Maintenance for AML With Internal Tandem Duplication Mutation of <i>FLT3</i>Mark J. Levis, Yves Béguin, Brent R. Logan et al.|Journal of Clinical Oncology|2024Cited by 204